Summary Alkaline phosphatase, a marker of differentiation in the human alveolar adenocarcinoma cell line A549, is inducible by conditioned medium from lung fibroblasts and by cytokines including oncostatin M and interleukin 6, but only in the presence of a glucocorticoid, dexamethasone. Dexamethasone was shown to induce incorporation of [3H]glucosamine into three fractions of medium and cell trypsinate from subconfluent A549 cells, eluting from DEAE ion-exchange chromatography. The first peak did not correspond to any of the unlabelled glycosaminoglycans and was not characterized further. Induction was seen in two other peaks, corresponding to hyaluronic acid and heparan sulphate. Of these, heparan sulphate, eluting as one well-defined peak (referred to as HS1) and another of lower activity and less well defined (HS2), was selected as the most likely to interact with growth factors and cytokines and was isolated from the eluate, concentrated and desalted, and used in alkaline phosphatase induction experiments in place of dexamethasone. HS1 isolated from the medium (HS1m) of subconfluent A549 cells was shown to replace dexamethasone in induction experiments with fibroblast-conditioned medium, oncostatin M and interleukin 6. HS1 from the cell trypsinate and HS2 from the medium and trypsinate were inactive. As the activity of HS1m could be abolished by heparinase and heparitinase but not by chondroitinase ABC, it was concluded that HS1 m was a fraction of heparan sulphate involved in the regulation of paracrine growth factor activity in lung fibroblast-conditioned medium, and in the regulation of other growth factors with potential roles in the paracrine control of cell differentiation.
Differentiation of the mature phenotype in alveolar type II pneumocytes is marked by the production of lipid pulmonary surfactant (PS) and surfactant-associated proteins (Hawgood and Clements, 1990) and by an increase in alkaline phosphatase (AP) activity (Edelson et al, 1988) . Perinatal induction of differentiation is mediated by glucocorticoids and a paracrine factor, or factors, from mesenchymally derived cells in the lung (Caniggia et al, 1991) . In vitro, the synthesis of pulmonary surfactant and alkaline phosphatase can be induced in A549, a cell line derived from a human lung adenocarcinoma (Giard et al 1972) , of reputedly type II cell origin (Lieber et al, 1976) , by conditioned medium from lung fibroblasts (CM) (Speirs et al, 1991) . Whereas induction of PS synthesis by CM was enhanced by treating the fibroblasts with dexamethasone (DX) before and during the conditioning process, DX was not required for the action of the CM on the A549 cells (Speirs et al, 1991) . It is, however, required for the induction of alkaline phosphatase by CM and by several cytokines, such as oncostatin M (OSM), interleukin 6 (IL-6), and interferons a and [3, and by insulin (McCormick et al, 1995; McCormick and Freshney, 1996) . OSM has been found to have the greatest activity and potency of all factors so far examined in the alkaline phosphatase assay, with a peak response of fivefold induction at 10 ng ml (McCormick and Freshney, 1996) in the presence of DX. It is inactive in the absence of DX. We have also shown that OSM increases the expression of the surfactant protein B gene in NCI-H441 cells (another putative type II or Clara cell-derived tumour cell line). Although combinations of cytokines, particularly with insulin, are active without DX, their activity is still significantly enhanced by DX. Preliminary experiments (J Paterson, J Sinclair and RI Freshney, unpublished observations) showed that A549 cells, treated with DX and then challenged with CM at intervals up to 5 days after DX removal, showed induction of AP by CM in the absence of DX. This suggested that the effect was stable and not due to receptor up-regulation or modifications in intracellular signalling, which would be expected to decay with a half-life of between a few minutes and several hours. Stable effects that might influence cytokine activity include modifications of the extracellular matrix by synthesis of glycosaminoglyans (GAGs), particularly heparan sulphate (HS), usually complexed with protein as proteoglycan (Lopez-Casillas et al, 1993; de Wynter et al, 1993; Femig and Gallagher, 1994) . Previous work with cell lines from human glioma showed that glucocorticoids cause a reduction in the synthesis of hyaluronic acid and an increase in HS, particularly cell-associated HS (Mackie et al, 1988) . Previously preliminary data had shown that A549 cells show enhanced 35SO42-incorporation in high molecular weight material released into the medium following DX treatment (McLean, 1986) , and this material shifted to a lower molecular weight after pronase digestion, suggesting that it may have been proteoglycan.
Paracrine growth factors and cytokines, such as IL-6 and inter- (Kohlhepp et al, 1987; Pfeffer and Eisenkfraft, 1991; Rose and Bruce, 1991; Bruce et al, 1992; Oberg, 1992; Lotem and Sachs, 1995) , constitute a potential modality for the treatment of malignant tumours. A partially purified factor from DX-treated lung fibroblasts was shown to inhibit growth of A549 cells grown as xenografts in nude mice (Speirs et al, 1991) . Separate studies have demonstrated that paracrine factors are present in CM from fibroblasts Speirs et al, 1991; McCormick et al, 1995 (1995) showed that pure, cloned, cytokines are active singly, provided that DX is present, so there are some stable active inducers of AP, many of which are reasonable candidates for paracrine factors released by lung fibroblasts. As their activity is dependent on DX however, it is important to determine the nature of this dependence, on the one hand to understand better the mechanism of growth factor and cytokine action and, on the other, to determine whether a purified activating factor could substitute for DX, which may not always be appropriate for clinical treatment, particularly if it is prolonged and repeated.
We have analysed medium and trypsinate from A549 cells, after treatment with DX, by anionic ion exchange chromatography, to determine whether cell-associated or soluble factors are produced under the influence of DX that could act as intermediates in the response to DX and substitute for DX in the induction process. We have shown that there is a marked stimulation of [3H]glucosamine ([3H]GLN) incorporation, particularly in the medium of subconfluent A549 cells, and that a fraction eluted from DEAE in 0.35 M sodium chloride, corresponding to an early-eluting fraction of HS, substitutes for DX in the induction of AP by CM and cytokines, such as IL-6 and OSM. This fraction, which we have called HS1, is present only after treatment of subconfluent cells with DX. An adjacent fraction of HS, which we have called HS2, eluting at 0.4 M sodium chloride and corresponding to the major peak of HS, shows no activity. HS1 and HS2 from cell surface-associated material, isolated following trypsinization, is also inactive. This activity of HS1 is sensitive to both heparinase and heparitinase, but not chondroitinase ABC and is probably, therefore, a species of heparan sulphate. Preparation of fibroblast-conditioned medium (CM) LF1 13 cells were grown to confluence, the serum reduced to 1%, and the confluent monolayer was maintained for 8 days, at which time the serum was removed and serum-free F1O:DMEM (SF) added for a further 3 days (McCormick et al, 1995) . This was collected and designated CM. It was frozen and thawed at least once and filtered through a 0.22-gm filter (Millex GV, Millipore) before use.
MATERIALS AND METHODS
Induction experiments A549 cells were seeded into microtitration plates at 5 x 104 ml-', 5000 per well, in 100 gl of F1O:DMEMIOFB, and grown for 3 days. The medium was replaced with SF with or without 0.25 gM dexamethasone and test compound(s). When CM was used it was diluted to 50% in F1O:DMEM. Alkaline phosphatase activity was determined after 24 or 72 h.
Alkaline phosphatase assay
Cells were grown in microtitration plates and, when ready for assay, were washed in 0.85% sodium chloride and frozen and thawed three times in 10 ,ul of 0.85% sodium chloride. Alkaline phosphatase was assayed by measuring the absorbance at 310 nm on a Biorad ELISA plate reader of p-nitrophenol (PNP) released of from p-nitrophenyl phosphate, using Sigma kit no. 104, following a 1-h incubation at 37°C. Activity is expressed as ,umol PNP released h-' 10-5 cells. Duplicate cell counts were performed on replicate plates.
Preparation and fractionation of glycosaminoglycans Labelling cells A549 cells were seeded at 5 x 104 ml-l in 75-cm2 flasks in FIO:DMEMlOFB and the medium replaced 24 h later with F1O:DMEMlOFB with or without 0.25 gM DX. After a further 48 h, 7 ml of the same medium, containing 110 kBq (3 ,Ci) ml-1 D-[1-3H]glucosamine [99.9 GBq (2.7 Ci) mmol-'] was added and the flasks incubated for a further 24 h. The medium from each flask was then diluted with an equal volume of 0.1 M Tris-HCl, pH 7.9, containing 1 mm calcium chloride and 3.0 mg ml-' pronase (Sigma-Aldrich), and incubated for 18 h at 55°C. The reaction was stopped by placing the tubes in a boiling bath for 2-3 min and the solution frozen at -70°C until required.
To prepare cell-associated GAGs, 2.0 ml of 0.05% trypsin (Life Technologies) in 0.1 M Tris-HCl, 0.05 M sodium chloride, pH 7.9 (TBS), was added to the washed cell layer and incubated for 15 min. The cells were resuspended and collected into a universal container, the flask washed with 2 ml of TBS containing 0.05% soya bean trypsin inhibitor (Sigma-Aldrich) and added to the cell suspension. This was centrifuged at 500 g for 5 min and the pellet resuspended in 7 ml of TBS and a further 7 ml of pronase, 3.0 mg ml-' in TBS, and incubated for 18 h at 55°C. The reaction was stopped by placing the tubes in a boiling bath for 2-3 min and the solution frozen at -70°C until required.
Chromatography
The pronase digest was thawed, concentrated tenfold on a Centriprep-3 (Whatman), diluted 1:10 with initial buffer (20 mM Tris-HCl, pH 8.4), loaded on to a DEAE Memsep filter on a ConSep intermediate pressure chromatography system (Perceptive Biosystems) and eluted with a stepped 0-0.6 M sodium chloride gradient (Juricova and Deyl, 1975 ) (see dotted line in Figure 1 ). Each fraction (1 ml) was diluted with 9.0 ml of scintillant and counted on a Packard Tricarb 1600 TR scintillation spectrometer. Commercially available GAGs (Sigma; hyaluronic acid (H0902) from bovine trachea, heparan sulphate (H7641) from bovine intestinal mucosa and chondroitin sulphate A (C8529) from bovine trachea) were run on the ConSep system under identical conditions and the concentration of GAGs in each fraction estimated by the carbazole assay (Bitter and Muir, 1962) . These data are presented in Figure IA , in which HA is hyaluronic acid, HS is heparan sulphate and CS is chondroitin sulphate.
Isolation of fractions
Fractions (usually no. 23 and no. 24, but determined by radioactivity profile; see Figure 1 ) were pooled to give HS 1 and no. 26, no. 27 and no. 28 to give HS2. These were concentrated tenfold on a prewashed Centriprep-3, diluted tenfold in F1O:DMEM and sterilized by filtration on a Millex GV filter (Millipore). The concentration of GAGs was determined by the carbazole assay and adjusted to the required amount. As HS 1 lost a third of its activity when stored at -80°C and two-thirds when stored at -20°C, it was used immediately after preparation.
Statistical analysis Data are presented as the means ± standard error of the mean. Pvalues were determined by the Student's t-test.
RESULTS

Requirement for DX for AP induction
Microtitration plate cultures of A549 cells were exposed to CM in the presence and absence of 0.25 JIM DX and to DX alone. DX alone induced AP as previously reported (McCormick et al, 1995) , with a mean ratio of four times the serum-free control (s.e.m. 0.92, P = 0.0014), CM alone gave slight induction in some experiments, although this was not significant overall (P = 0.18), but CM in the presence of DX gave a twofold induction of AP activity over DX alone (P = 0.12) and sixfold over CM alone (P < 1 x 10-4) ( Table  1) . Cell counts showed a slight (average 20%) cytostatic effect of DX, but this was not significant when analysed over the seven experiments.
Effect of DX on incorporation of [3H]GLN incorporation
Flask cultures were labelled with [3H1GLN for 24 h after 3 days' exposure to 0.25 gM DX during the exponential, early plateau and late plateau phase of the growth cycle, and the GAGs in the medium and trypsinate analysed as described in Materials and methods. The elution profile of unlabelled GAGs (Sigma) are shown with the salt gradient used in Figure IA .
Medium from subconfluent cells There was a marked stimulation of incorporation of [3H]GLN following exposure to DX (Figure iB) . The largest peak (P1), eluting at 0.15 M sodium chloride, did not correspond to any of the unlabelled GAGs run under identical conditions, and may have been non-GAG-related oligosaccharides or degraded GAGs. The second peak (P2) eluted at 0.25 M sodium chloride and corresponded to the position of hyaluronic acid. The third peak (P3) was heterogeneous, with a sharp peak eluting at 0.35 M sodium chloride (P3a) and a shoulder (P3b), eluting over the range from 0.36 to 0.4 M sodium chloride. P3 corresponded to the position of the unlabelled heparan sulphate, the bulk of which eluted at 0.4 M sodium chloride. Only relatively minor incorporation eluted in the region of chondroitin sulphate (P4), which would also coincide with dermatan sulphate, which elutes at approximately the same salt concentration.
Medium from confluent (early plateau phase) cells
Although there was still stimulation of [3H]GLN uptake into P3a in the presence of DX, this was considerably reduced to about 10-20% relative to 20-fold stimulation in subconfluent cells ( Figure IC) . The total incorporation into both DX-treated and controls was lower by an order of magnitude, and P1 and P2 were reduced five-to tenfold by DX treatment ( Figure IC) . The only effect of removal of serum was the disappearance of P2 (data not shown).
Medium from post-confluent (late plateau phase) cells Cells labelled after exposure to DX after 8 days in plateau showed a further twofold reduction in incorporation and inhibition of P1 by DX ( Figure Id Figure 2B ).
Trypsinate from post-confluent (late plateau phase) cells
Incorporation was reduced throughout. Although a small P3a peak was seen, stimulation by DX was not consistently observed. The activity of DX was mainly inhibitory, particularly in P1 and P4 ( Figure 2C ).
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this by 20% (P = 0.005). When DX was added to CM + HS1 from DX-treated A549 cells, during induction of AP, there was no further increase in AP activity and, in fact, AP was reduced by 10% (P = 0.04) (data not shown). Dose-response curves of HS 1 showed optimal activity at around 5 gg ml-' ( Figure 5 ).
Effect of GAG-degrading enzymes
Heparinase reduced the activity of HS1 by 94% after 8 h (P < 1 x 106) and 99.5% after 31 h (P < 10-) ( Figure 6A ). Heparitinase reduced the activity of HS1 by 97% (P < 1 x 10-10). Radioactivity in peak P3a, rechromatographed after enzymatic digestion, was reduced 81% by heparinase and 88% by heparitinase (data not shown). Chondroitinase ABC had no significant effect on the activity of HS 1 (P = 0.4) ( Figure 6B ) and only reduced rechromatographed P3a by 2% (data not shown).
Effect of HS1 on activity of cytokines IL-6 and OSM, previously shown to be active in the induction of AP in A549 cells (McCormick et al, 1995; McCormick and Freshney, 1996) , with optimal activity at 2.5 ,ug ml-' and 10 ng ml-' respectively, were used to induce AP in A549 cells, in the presence and absence of DX or HS1. While OSM at 10 ng ml-' induced AP fivefold in the presence of 0.25 gM DX (P < 1 x 10-5), it induced AP more than sevenfold in the presence of 5.0 jg ml-' HS1 (P < l x 10--vs OSM alone; P = 0.0013 vs OSM + DX). Similarly, while IL-6 at 2.5 jg ml-' induced AP threefold in the presence of 0.25 jM DX (P < -0.005), it induced AP nearly sevenfold in 5.0 jg ml-' HS1 (P < 1 x 10-5 vs IL-6 alone; P < 0.0005 vs IL-6 + DX) (Figure 7 ).
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DISCUSSION
The activity of many growth factors, such as FGF-2 and TGF-,, is regulated by their binding to soluble and membrane-bound lowaffinity receptors (Ruoslahti et al, 1992; Lopez-Casillas et al, 1993; de Wynter et al, 1993; Piepkorn et al, 1994; Strain et al, 1994; Walker et al, 1994) , many of which are proteoglycans. The role of these receptors is not entirely clear, but they may be involved in sequestration and/or stabilization (McCaffrey et al, 1994) , or translocation of the growth factor to the high-affinity receptor (Klagsbrun and Baird, 1991; Ruoslahti et al, 1992) . As DX was shown to enhance the activity of growth factors involved in A549 differentiation (although not the activity of FGF-2) (McCormick et al, 1995) , and preliminary data suggested that the effect was stable after removal of DX, this suggested that a matrix constituent might be involved, particularly as previous work (McLean, 1986; Mackie et al, 1988) (1997) 
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The 0.35 M sodium chloride peak, designated P3a, corresponded to a low-salt-eluting fraction of heparan sulphate. As previous reports have implicated the heparan sulphate group of proteoglycans in growth factor binding (Klagsbrun and Baird, 1993; de Wynter et al, 1993) , this peak was selected for further study. The induction of this peak was seen in both the medium and the trypsinate of subconfluent cells, but not in confluent and post-confluent cultures. Induction in the medium was much greater than that in the trypsinate, in which induction of P3b (0.4 M sodium chloride eluate) was found to be greater. When material from the medium and trypsinate of subconfluent cultures was isolated (designated HS 1 from the highest radioactivity fraction in P3a, and HS2 from the middle of P3b) and used instead of DX in the induction of alkaline phosphatase in A549 cells by CM, only HS 1 from the medium was found to be active (Figure 3) . Cell-associated (trypsinate) HS1 was inactive, and both cell-associated and soluble HS2 were unable to replace DX, although HS2 from the trypsinate and the medium gave 30% and 40% induction with CM, minor effects compared with HS 1 from the medium. HS 1 from the medium had no inductive activity alone. HS2 from the medium induced AP twofold, in the absence of CM, whether from DX-treated or untreated A549 cells. However, as these effects were slight compared with the effect of HS1 from A549 medium, they were not investigated further.
HS 1 was also active in replacing DX in the induction of AP by OSM and IL-6, with HS1 giving a higher response to cytokine than DX in both cases.
Although HS 1 isolated from medium and trypsinate was used in the AP assay at the same concentration in control cells, i.e. without DX pretreatment, pooling the d.p.m. per 106 cells from fractions 20-25 showed that about four times as much [3H]GLN incorporation appeared in the medium as in the trypsinate (Table 2) . After DX treatment, incorporation in the medium increased 37-fold, whereas that in the trypsinate only increased 2.4-fold, giving a new ratio of medium to trypsinate of 65-fold. As HSI from the medium was by far the most active, HS1 from the trypsinate, which only increased 2.4-fold with DX as opposed to 37-fold in the medium, was not analysed further.
It is not clear why this activity is not cell associated, as one might expect if it performed the role of a low-affinity translocating receptor, but it may be due to the transformed nature of the A549 cells, where surface proteolysis may release membrane-bound proteoglycans into the medium. Skinner et al (1987) found the ratio of proteoglycans between medium and the cell layer to be similar in rat type II cells in culture, but found that both fractions were reduced with cortisol. Whether this difference is due to species, developmental stage or transformation is not clear.
Prior incubation of HS 1 with heparinase or heparitinase, both of which cleave heparan sulphate, destroyed its activity, but incubation with chondroitinase ABC, which is inactive against heparan sulphate but degrades chondroitin sulphate and hyaluronic acid, had no effect. As heparitinase acts specifically on heparan sulphate (Jandik et al, 1994) , this suggests that the active material is a species of heparan sulphate. As the purified material was protease treated before fractionation, and only minimal absorbance at 280 nm was observed around the active fractions, suggesting that little residual protein remained, the activity may lie in the carbohydrate moiety. However, the presence and activity of small residual peptide chains cannot be totally excluded.
It is surprising that IL-6 synthesis has been shown to be downregulated by DX in lung fibroblasts (McCormick et al, 1995) , whereas HS 1 is stimulated in the target cells that respond to IL-6. However, IL-6 may not be the main paracrine factor from fibroblasts responsible for A549 cell and type II cell differentiation, and the main candidate, FPF, which has been shown to be up-regulated in perinatal lung fibroblasts by cortisol , still remains to be identified.
Although many growth factors are dependent on binding to HS for activation, there is no record of this for IL-6 or OSM, although Han et al (1996) observed potentiation of IL-6 by heparin and HS in haematopoietic cells. This may be a new species of HS that interacts with the IL-6 group of cytokines, as we have previously (McCormick and Freshney, 1996) seen DX-dependent activity in LIF as well as OSM and other members of the IL-6 group. However, DX is also required for the inductive action of insulin and IFN-3 in this system (McCormick et al, 1995) , and it would be surprising to find a common reactive species of HS for such a disparate group. It is possible that each of these agents is capable of inducing the production of an autocrine factor by A549 cells (Stadnyk, 1994) . This autocrine factor may be HS dependent and activated by HS 1. The current data suggest that untreated A549 cells do not make this autocrine factor constitutively as HS 1 is not active alone. ABBREVIATIONS AP, alkaline phosphatase; CM, fibroblast-conditioned medium; DMEM, Dulbecco's modification of Eagle's medium; DX, dexamethasone; FIO:DMEM, 50:50 mixture of Ham's FIO and DMEM; FPF, fibrocyte-pneumocyte factor; GAG, glycosaminoglycan; GLN, glucosamine; HA, hyaluronic acid; HS, heparan sulphate; IL-6, interleukin 6; LIF, leukaemia inhibitory factor; OSM, oncostatin M; PNP, p-nitrophenol; PS, pulmonary surfactant; SF, serum-free FIO:DMEM medium.
